Leadiant fined for pharma dominance abuse, Dutch watchdog says
MLex Summary: Drugmaker Leadiant has been fined almost 19.6 million euros for abusing its dominant position, the Dutch competition watchdog has said. The company was found to have charged excessive prices...To view the full article, register now.
Already a subscriber? Click here to view full article